DCB Open Innovation Challenge: The top 3 devices have been selected

The jury together with finalist John Wilcox during the pitch day. Photo: André Raul Surace

Of the TOP 20 teams that pitched their idea to the DCB Innovation Jury last Tuesday, the following three teams were selected for the finals:

Ole Kjerkegaard Nielsen (DK) – GO-Pen: Affordable insulin pen for all

“We believe everybody should have equal access to quality diabetes care. The GO-PEN(TM) is a refillable insulin pen that works with a broad range of insulins and provides the same advantages as any prefilled insulin pen compared to injecting insulin from vials using syringes.“

John Wilcox (US) – SmartFusion: A Next Generation Insulin Infusion Monitoring Platform

“SmartFusion is an infusion monitoring platform for people with insulin pumps and automated insulin delivery devices. Our technology works by analyzing historical and real-time data from insulin pumps + continuous glucose monitors to better detect the occurrence of infusion set failure and reduce severe hyperglycemia from insulin dosing.”

Ben Delhey (FR) – Lassie: The first non-invasive breath analyzer for people with diabetes

“We give people access to gentle non invasive health monitoring starting with Diabetes. We leverage molecules (Volatile organic compounds) present in exhaled breath and correlated with glucose biomarker to calculate accurately the value of Glucose in real-time and very user-friendly way.”

The three finalists will attend a one-week innovation bootcamp in Switzerland in the end of June. The final pitches and award ceremony will take place on 30 November 2022 at the sitem-insel in Bern together with the top 3 teams of the category Digital Diabetes starting mid-July. The three winning teams will receive a total price of 200,000 US dollars, along with additional support. The DCB Innovation Challenge award is one of the world’s most generous and renowned diabetes-related awards.